[ <sup>18</sup> F]PSMA-1007 PET/MR as a Precision Biomarker for Early Detection of Biochemical Recurrence in Prostate Cancer at Very Low PSA Levels
PSMA-PETMR significantly improves the detection of recurrent PCa in patients with very low PSA levels, offering precise lesion localization and supporting personalized treatment approaches. Further studies are needed to optimize its clinical use and validate its long-term benefits.
Authors
- Yuh‐Feng Wang (ORCID: https://orcid.org/0000-0002-0403-0536)
- Ko-Han Lin (ORCID: https://orcid.org/0000-0002-1464-3483)
- Mei‐Hua Chuang (ORCID: https://orcid.org/0000-0002-0649-9709)
- Tzu-Chun Wei (ORCID: https://orcid.org/0000-0001-5224-200X)
- Shu-Huei Shen (ORCID: https://orcid.org/0000-0002-5871-3092)
- Wentao Huang (ORCID: https://orcid.org/0000-0003-0843-2417)
- William Ji-Shien Huang
- Nan-Jing Peng
Institutions
- National Yang Ming Chiao Tung University (TW)
- Yuanpei University (TW)
- Taipei Veterans General Hospital (TW)
- Mackay Junior College of Medicine, Nursing and Management (TW)
Publication Details
- Journal
- Biomarker Insights
- Published
- 2025-03-12
- DOI
- https://doi.org/10.1177/11772719251324307
- Citations
- 3
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 4.56